By Kathrin Folkendt News, Pharma, Reproductive Health January 21, 2026 ShareTwitterFacebookPinterest-circled FDA Approves Five-Year Duration of Use for Organon’s Nexplanon Contraceptive Implant
By Femtech Insider Acquisition, Biotech, Brain Health and Cognitive Health, News, Pharma December 17, 2025 ShareTwitterFacebookPinterest-circled ADEL Signs $1.04 Billion Licensing Deal with Sanofi for Alzheimer’s Antibody Therapy
By Femtech Insider News, Pharma, Sexual Wellness December 11, 2025 ShareTwitterFacebookPinterest-circled Daré Bioscience Opens Pre-Orders for Topical Sildenafil Cream for Female Arousal
By Femtech Insider News, Pharma, Uncategorized December 10, 2025 ShareTwitterFacebookPinterest-circled Roche Launches Bacterial Vaginosis and Candida Vaginitis Diagnosis Test Following CE Mark Approval
By Femtech Insider Breast Health, Cancer, News, Pharma November 26, 2025 ShareTwitterFacebookPinterest-circled FDA Approves First Pertuzumab Biosimilar for HER2-Positive Breast Cancer Treatment
By Femtech Insider Breast Health, Cancer, News, Pharma November 21, 2025 ShareTwitterFacebookPinterest-circled Roche’s Giredestrant Shows Positive Phase III Results in Early Breast Cancer Trial
By Femtech Insider Menopause, News, Pharma, Policy November 11, 2025 ShareTwitterFacebookPinterest-circled FDA Removes Black Box Warnings from Menopausal HRT Products
By Femtech Insider Maternal Health, Medical Device, News, Pharma, Pregnancy November 7, 2025 ShareTwitterFacebookPinterest-circled Laborie to Acquire JADA System from Organon for Up to $465 Million
